| Title |
Real-World Evaluation of a Pharmacoinvasive Strategy for STEMI in Latin America: A Cost-Effective Approach with Short-Term Benefits
|
|---|---|
| Published in |
Therapeutics and Clinical Risk Management, November 2023
|
| DOI | 10.2147/tcrm.s432683 |
| Pubmed ID | |
| Authors |
Alexandra Arias-Mendoza, Jorge A Ortega-Hernández, Diego Araiza-Garaygordobil, Héctor González-Pacheco, Mireya Martínez-García, Enrique Hernández-Lemus, Rodrigo Gopar-Nieto, Tomás Tadeo Sandoval-Aguilar, Daniel Sierra-Lara Martinez, Salvador Mendoza-García, Alfredo Altamirano-Castillo, José Luis Briseño-de-la-Cruz, Midori Alondra Ortega-Hernández, Luis Alejandro Soliz-Uriona, Jorge Gaspar-Hernández |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 5 | 63% |
| Bolivia, Plurinational State of | 1 | 13% |
| Unknown | 2 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 2 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 1 | 50% |
| Student > Bachelor | 1 | 50% |
| Readers by discipline | Count | As % |
|---|---|---|
| Economics, Econometrics and Finance | 1 | 50% |
| Medicine and Dentistry | 1 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 November 2023.
All research outputs
#6,450,531
of 25,394,764 outputs
Outputs from Therapeutics and Clinical Risk Management
#312
of 1,323 outputs
Outputs of similar age
#90,749
of 357,109 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#2
of 8 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 357,109 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than 6 of them.